Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2003
10/01/2003EP1348024A2 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
10/01/2003EP1347991A2 Amphipathic peptides and their use for transferring substances of interest into cells
10/01/2003EP1347989A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs
10/01/2003EP1347789A2 Hot melt adhesives for dermal application
10/01/2003EP1347783A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units
10/01/2003EP1347782A1 Compositions comprising cyclodextrins and no-releasing drugs
10/01/2003EP1347781A1 Oral pharmaceutical compositions containing cyclodextrins as taste masking agent
10/01/2003EP1347780A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
10/01/2003EP1347776A2 Anti-inflammatory use of polycationic compounds
10/01/2003EP1347775A2 Uses for polycationic compounds as vaccine adjuvants
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347765A2 Dermatological formulations
10/01/2003EP1347764A2 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism
10/01/2003EP1347760A2 Nmda receptor agonist pharmaceutical compositions
10/01/2003EP1347756A2 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart
10/01/2003EP1347749A2 Transdermal therapeutic system comprising the active ingredient oxybutynin
10/01/2003EP1347748A2 Hydrostatic delivery system for controlled delivery of agent
10/01/2003EP1347747A2 Method for preparing submicron particle suspensions
10/01/2003EP1347746A1 Over-coated chewing gum formulations including tableted center
10/01/2003EP1347744A1 Solid dispersions of nitrate active principles
10/01/2003EP1347743A2 Composition for treatment of inflammatory disorders
10/01/2003EP1347742A1 Sustained release drug delivery devices with prefabricated permeable plugs
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1202996B1 Titanium derived compounds, preparation and use thereof
10/01/2003EP1109838B1 Redispersible powder and its aqueous dispersion, preparation process and use
10/01/2003EP1097712B1 Steroid-containing cataplasms and process for producing the same
10/01/2003EP1096994B1 Liquid thickener for surfactant systems
10/01/2003EP1094843B1 Targeted site specific drug delivery compositions and uses
10/01/2003EP1051190B1 Vaccine compositions for mucosal administration comprising chitosan and influenza antigen(s)
10/01/2003EP1037666B1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
10/01/2003EP1028723B1 Stabilized ascorbic acid, composition, and method of use
10/01/2003EP0999854B1 Switchable viscoelastic systems containing galactomannan polymers and borate
10/01/2003EP0999825B1 Ophthalmic compositions containing galactomannan polymers and borate
10/01/2003EP0998266B1 Microcrystalline cellulose: alginate pharmaceutical suspensions
10/01/2003EP0914098B1 Multi-layered osmotic device
10/01/2003EP0914043B1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/01/2003EP0904056B1 Process and device for inhalation of particulate medicaments
10/01/2003EP0863917B1 Targeted cytotoxic anthracycline analogs
10/01/2003EP0833606B1 Stable hydroalcoholic compositions
10/01/2003EP0814780B1 Diltiazem controlled release formulation
10/01/2003EP0810854B1 Aerosols containing beclomethazone nanoparticle dispersions
10/01/2003EP0804153B1 Composition comprising a tissue glue and an immobilised therapeutic particle
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446094A Method for obtaining antigenic structures enhancing specific cross reactivity
10/01/2003CN1446093A Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity
10/01/2003CN1446092A Aqueous pharmaceutical compositions
10/01/2003CN1446089A Pharmaceutical composition containing citalopram
10/01/2003CN1446083A Coated medicament forms with controlled active substance rdease
10/01/2003CN1446082A ÔÇ£Slow releaseÔÇØ pharmaceutical compositions comprising lithium carbonate
10/01/2003CN1446081A 神经毒素植入物 Neurotoxin implants
10/01/2003CN1446080A Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
10/01/2003CN1446079A Liposomal antineoplastic drugs and uses thereof
10/01/2003CN1446077A Inhaleable spray dried 4-holix bundle protein powders having minimized aggregation
10/01/2003CN1445367A Biofilm carrier with improved specific surfacial area, bio-affinity and flowability
10/01/2003CN1444948A Liposome of Breviscapine and its preparing method
10/01/2003CN1444926A Bio-adhesiveness drug release system
10/01/2003CN1444925A Long acting injection containing ethyl cellulose for animal
10/01/2003CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/01/2003CN1122535C Substituted amylose as miatrix for sustained drug release
10/01/2003CN1122534C Method for reducing side effects of drug
09/2003
09/30/2003US6627744 Synthesis of glycodendrimer reagents
09/30/2003US6627738 No-modified hemoglobins and uses therefor
09/30/2003US6627663 Especially medicaments containing verapamil; a lecithin/isopropyl myristate solution; butylated hydroxy toluene; pluronic F127; an antioxidant agent suspended in a carrier
09/30/2003US6627620 Composition set and kit for use in intraocular surgery
09/30/2003US6627616 Intravascular delivery of non-viral nucleic acid
09/30/2003US6627615 Methods and compositions for in vivo gene therapy
09/30/2003US6627601 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier
09/30/2003US6627600 Time-release implant of drug dispersed in biodegradable polymer; shape retention; nonfused; no need for suspending fluid
09/30/2003US6627440 Recombinant human alpha-fetoprotein as a cell proliferative agent
09/30/2003US6627234 Method of producing active agent coated chewing gum products
09/30/2003US6627231 Protecting cell from damage caused by free radicals by administering lipophilic antioxidant comprising vitamin E, beta carotene, extract of Lycopersicum esculentum, hydrophilic antioxidant comprising vitamin c, extract of vitis vinifera
09/30/2003US6627228 Polymeric delivery agents and delivery agents compounds
09/30/2003US6627225 Gellan gum tablet coating
09/30/2003US6627224 Low dose entecavir formulation and use
09/30/2003US6627223 Timed pulsatile drug delivery systems
09/30/2003US6627221 Unit dose containing less than 5% by weight of stearic acid lubricant in the outer phase, relative to the total weight have good dissolution rate, heat resistance and storage stability for drugs such as ibandronate sodium
09/30/2003US6627218 Cationic lipid with a lipophilic group derived from cholesterol; an amide or carbamate linker bond; an alkylene spacer arm; and a cationic primary, secondary, tertiary or quaternary amino group. facilitating nucleic acid transfer
09/30/2003US6627217 External preparation
09/30/2003US6627216 Liquid composition
09/30/2003US6627215 Devices for improved wound management
09/30/2003US6627214 Adding fumaric acid to reduce throat burn sensation
09/30/2003US6627212 Containing titanium dioxide platelets
09/30/2003US6627211 Vehicle containing alcohol, glycol and biological surfactant
09/30/2003US6627210 Alpha-2-adrenergic agonist component is selected from the group consisting of imino-imidazolines, imidazolines, imidazoles, azepines, thiazines, oxazolines, guanidines, catecholamines and derivatives or mixtures
09/30/2003US6627209 Implanting stent having biodegradable carrier coating and calcium channel blocker
09/30/2003US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
09/30/2003US6627197 Selective destruction of cells infected with human immunodeficiency virus
09/30/2003US6627187 Containing an amino acid as a stabilizer; long term storage stability
09/29/2003CA2423915A1 Process for producing nanoparticles of paclitaxel and albumin
09/29/2003CA2423884A1 Improved paclitaxel-based antitumor formulation
09/25/2003WO2003079403A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
09/25/2003WO2003078569A2 Targeting of myocardial angiogenesis through cd13/apn
09/25/2003WO2003078508A1 Polymer composite with internally distributed deposition matter
09/25/2003WO2003078429A1 Micronized crystalline tiotropium bromide
09/25/2003WO2003078387A1 Formulations of anthraquinone derivatives
09/25/2003WO2003078049A1 Vesicles comprising an amphiphilic di-block copolymer and a hydrophobic compound.
09/25/2003WO2003077967A1 Deposition method for endoprostheses provided for constantly administering medicaments
09/25/2003WO2003077953A2 Bacteriophage composition
09/25/2003WO2003077952A1 Topical composition comprising a cyclofructan, a carrier and a drug
09/25/2003WO2003077951A1 Percutaneous absorption promoters and compositions for treating athlete’s foot
1 ... 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 ... 1712